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Some of the compounds containing the quinazoline moiety show fungicidal, antimicrobial, CNS-dependent, anti-cancer, anti-hypertensive 1 and anti-HIV activities. 2 Some derivatives of indole [1,2c] quinazoline show cataleptogenic activity. 3 A structure analysis provides an opportunity to study biological activity and its implication in the structural requirement needed for binding to the receptors. The present study was undertaken in order to study the influence of the substituent groups on the conformation of the quinazoline ring system, which also forms a part of our continuing study of biologically active compounds. In view of the above, we report herein the synthesis and crystal structure of the title compound.
A mixture of o-aminophenylbenzimidazole (0.05 mol, 10.45 g) and valeraldehyde (0.05 mol, 4.31 g) was refluxed in 200 ml of alcohol for 5 h. The resulting solution was concentrated under reduced pressure to a small volume to obtain a yellow compound. It was filtered and recrystallized from alcohol to obtain a cream-colored crystalline compound (yield 60%; melting point 120˚C). A schematic diagram of the molecule is shown in Fig. 1 .
A single crystal of the title compound with dimensions 0.3 × 0.27 × 0.25 mm was chosen for an X-ray diffraction study. The data were collected on a DIPLabo Image Plate system with graphite-monochromated Mo Kα radiation. Thirty six frames of data were collected by the oscillation method. Each exposure of the image plage was set to a period of 400 s. Successive frames were scanned in steps of 5˚ per min with an oscillation range of 5˚. Image processing and data reduction were performed using Denzo. 4 All of the frames could be indexed using a primitive monoclinic lattice. The details of the crystal data and refinement are given in Table 1 . The structure was solved by direct methods using SHELXS-97. All of the non-hydrogen atoms could be located in the first Fourier map, itself. Refinement with anisotropic parameters for the non-hydrogen atoms saturated the residuals to R1 = 0.0693. The hydrogen atoms were placed at chemically acceptable positions, and were allowed to ride on their parent atoms. An ORTEP diagram of the molecule with thermal ellipsoids at 50% probability is shown in Fig. 2 . Table 2 gives the selected bond distances and bond angles of the non-hydrogen atoms. The bond distances and bond angles are in good agreement with the standard values.
The benzene and imidazole rings of the molecule are planar, but the quinazoline ring system deviates from planarity with the atom N14 lying 0.190(2)Å from the N14-C15-N16-C7-C8-C13 least-squares plane. A study of the torsion angles, asymmetric parameters and least squares plane calculations reveals that the dihydropyrimidine ring is in the envelope conformation. The torsion angles about N14-C15-C18-C19 and N16-C15-C18-C19 are -57.3(2)˚ and -177.42(16)˚, respectively, which determine the conformation of the junction between the chlorophenyl and the quinazoline ring systems. The butyl moiety is in the antiperiplanar (trans) conformation, as indicated by the torsion angle of C18-C19-C19-C20 = -171.3(2)˚. The ring-puckering 5 analysis shows that the dihydropyrimidine ring has a puckering amplitude of Q2 = 0.3322(19)Å, a weighted-average ring bond distance of 1.4193(9,183)Å and a weighted-average absolute torsion angle of 21.47(10,613)˚.
The structure exhibits intermolecular hydrogen bonds of the type N-H·N between the imidazole and the quinazoline moieties. The intermolecular hydrogen bond, N14-H14·C16 has a length of 2.971(2)Å and an angle of 159˚ with symmetry code 1/2 + x, 1/2-y, 1/2 + z. The molecules are stacked in pairs when viewed along the a axis and form a polymeric chain, as shown in Fig. 3 .
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